期刊文献+

非糖尿病腹膜透析患者糖化血红蛋白水平与冠状动脉狭窄的相关性

Correlation between glycosylated hemoglobin and magnitude of coronary artery stenosis in non-diabetic patients receiving abdominal dialysis
下载PDF
导出
摘要 目的:探讨非糖尿病腹膜透析惠者糖化血红蛋白(HbAlc)水平与冠状动脉狭窄的相关性。方法:分析2011年1月至2013年7月在百色市人民医院进行持续不卧床腹膜透析治疗的38例非糖尿病成年慢性肾脏病患者的临床资料,按照有无冠状动脉狭窄将患者分为对照组(20例)和冠状动脉狭窄组(18例)。比较两组危险因素及检验指标的差异,分析冠状动脉狭窄的影响因素。结果:冠状动脉狭窄组的收缩压、FBG、2 hPBG、LDL-C、TC和HbAlc均高于对照组(P<0.05)。冠状动脉狭窄与年龄、收缩压、FBG、2hPBG、LDL-C、TC、HbAlc呈正相关(P<0.05),而HbAlc对冠状动脉狭窄的影响最大。结论:在非糖尿病腹膜透析患者中,HbMc水平与冠状动脉狭窄呈正相关,HbAlc可能是冠状动脉狭窄的预测因子。 Objective:To investigate the correlation between glycosylated hemoglobin (HbAlc) and the magnitude of coronary artery stenosis in non-diabetes mellitus patients receiving abdominal dialysis. Methods: We analyzed the clinical profiles of 38 non-diabetic patients with chronic kidney disease who were receiving ambulatory abdominal dialysis in Baise People' s Hospital between January 2011 and July 2013. Patients were further stratified to control group (n =20) and coronary artery stenosis group (n = 18) for comparison on the risk fators and the clinical indices. Results : The coronary artery stenosis group yielded higher levels of systolic blood pressure, FBG, 2hPBG, LDL-C, TC and HbAlc than control group ( all P 〈 0.05). The magnitude of coronary artery stenosis was positively correlated with the age, systolic blood pressure, FBG, 2hPBG, LDL-C, TC and HbAlc (all P 〈 0. 05, in particular the level of HbAlc. Conclusion: In non-diabetic patients receiving abdominal dialysis, the level of HbAlc is positively correlated with the magnitude of coronary artery stenosis, suggesting that it is a predictor of coronary artery stenosis.
出处 《广州医学院学报》 2013年第6期26-29,共4页 Academic Journal of Guangzhou Medical College
关键词 冠状动脉狭窄 腹膜透析 非糖尿病 糖化血红蛋白 coronary artery stenosis abdominal dialysis non-diabetes mellitus glycosylated hemoglobin
  • 相关文献

参考文献10

二级参考文献53

  • 1余金明,布艾加尔,王领军,李觉,肖伟林,陈芳,刘艺敏,邹莉玲,王宇,胡大一.高危人群踝臂指数影响因素的多元回归分析[J].上海医学,2006,29(1):4-6. 被引量:12
  • 2沈琴,贾伟平,包玉倩,陆俊茜,陆惠娟,左玉华,杜颉,刘兰花,方蓉.社区糖尿病及糖调节受损人群周围血管病变的患病率调查[J].中华医学杂志,2006,86(22):1530-1533. 被引量:41
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 4SALVATORE N. Classification, epidemiology, risk factors,and natural history of peripheral arterial disease[J]. Disb Obes Metab, 2002,4(Suppl2) : S1 -S6.
  • 5LI J, LUO Y, XU Y, et al. Risk factors of peripheral arterial disease and relationship between low anklebrachial index and mortality from all-cause and cardiovascular disease in Chinese patients with type 2 diabetes[J]. Circ J,2007, 71 :377-381.
  • 6MCDERMOTT M M, GREENLAND P, LIU K, et al. The ankle brachial index is associated with leg function and physical activity.. The Walking and Leg Circulation Study[J]. Ann Intern Med,2002,136:873 -883.
  • 7Elizabeth Selvin, Thomas P. Erlinger. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey[J]. Circulation. 2004, 110:738-743.
  • 8OSTERGREN J, SLEIGHT P, DOGENAIS G, et al. Impact of rampril in patients with evidence of clinical or subclinical peripheral arterial disease[J]. Eur Heart J,2004,25:17-24.
  • 9DUPREZ D. Hope brings hope for the use of anklebrachial index as cardiovascular risk marker[J]. Eur Heart J,2004,25:1-25.
  • 10FOWKES F G. The measurement of atherosclerotic peripheral arterial disease and epidemiological surveys [J]. Int J Epidemiol,1988,17:248.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部